Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2008 Sep;83(9):1032–1045. doi: 10.4065/83.9.1032

FIGURE 2.

FIGURE 2

A, Nitrogen-containing bisphosphonates selectively inhibit farnesyl pyrophosphate synthase (FPPS) within osteoclasts. B, Osteoclast endocytosis of bisphosphonate from the bone surface leads to FPPS inhibition and osteoclast apoptosis. BP = nitrogen-containing bisphosphonate; HMG-CoA = 3-hydroxy-3-methylglutaryl coenzyme A.